Citation: Wj. Wechter et Ed. Murray, HAS THE ELUSIVE NATRIURETIC FACTOR BEEN DISCOVERED, AND IF SO, IS IT A HORMONE, Experimental nephrology, 6(6), 1998, pp. 488-490
Authors:
WECHTER WJ
MCCRACKEN JD
KANTOCI D
MURRAY ED
QUIGGLE D
LEIPOLD D
GIBSON K
MINEYAMA Y
LIU YJ
Citation: Wj. Wechter et al., MECHANISM OF ENHANCEMENT OF INTESTINAL ULCEROGENICITY OF S-ARYL PROPIONIC ACIDS BY THEIR R-ENANTIOMERS IN THE RAT, Digestive diseases and sciences, 43(6), 1998, pp. 1264-1274
Authors:
MCCRACKEN JD
MINYAMA Y
MURRAY ED
KANTOCI D
QUIGGLE DD
LEIPOLD DD
WECHTER WJ
Citation: Jd. Mccracken et al., INCREASED EXPRESSION OF SALIVARY-GLAND EGF IN THE MIN + MOUSE IS REVERSED BY R-FLURBIPROFEN/, Gastroenterology, 114(4), 1998, pp. 2643-2643
Authors:
KANTOCI D
WECHTER WJ
MURRAY ED
DEWIND SA
BORCHARDT D
KHAN SI
Citation: D. Kantoci et al., ENDOGENOUS NATRIURETIC FACTORS .6. THE STEREOCHEMISTRY OF A NATRIURETIC GAMMA-TOCOPHEROL METABOLITE LLU-ALPHA, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 648-656
Authors:
MURRAY ED
WECHTER WJ
KANTOCI D
WANG WH
PHAM T
QUIGGLE DD
GIBSON KM
LEIPOLD D
ANNER BM
Citation: Ed. Murray et al., ENDOGENOUS NATRIURETIC FACTORS .7. BIOSPECIFICITY OF A NATRIURETIC GAMMA-TOCOPHEROL METABOLITE LLU-ALPHA, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 657-662
Authors:
WECHTER WJ
KANTOCI D
MURRAY ED
QUIGGLE DD
LEIPOLD DD
GIBSON KM
MCCRACKEN JD
Citation: Wj. Wechter et al., R-FLURBIPROFEN CHEMOPREVENTION AND TREATMENT OF INTESTINAL ADENOMAS IN THE APC(MIN)- IMPLICATIONS FOR PROPHYLAXIS AND TREATMENT OF COLON-CANCER( MOUSE MODEL ), Cancer research, 57(19), 1997, pp. 4316-4324
Authors:
WILLIAMS S
WAKISAKA A
ZENG QQ
BARNES J
MARTIN G
WECHTER WJ
LIANG CT
Citation: S. Williams et al., MINOCYCLINE PREVENTS THE DECREASE IN BONE-MINERAL DENSITY AND TRABECULAR BONE IN OVARIECTOMIZED AGED RATS, Bone, 19(6), 1996, pp. 637-644
Citation: Wj. Wechter et al., CHARACTERIZATION OF 2 NEW ENDOGENOUS NATRIURETIC FACTORS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2867-2867
Citation: Wj. Wechter, OVERVIEW OF THE ACCP SYMPOSIUM ON CHIRAL PHARMACOLOGY, WASHINGTON, DC, SEPTEMBER 23, 1995, Journal of clinical pharmacology, 36(6), 1996, pp. 485-487
Citation: D. Kantoci et Wj. Wechter, CALCULATION OF INVERSION HALF-LIVES OF ARYL PROPIONIC-ACID CLASS NONSTEROIDAL ANTIINFLAMMATORY DRUGS, Journal of clinical pharmacology, 36(6), 1996, pp. 500-504
Authors:
MCCRACKEN JD
WECHTER WJ
LIU YJ
CHASE RL
KANTOCI D
MURRAY D
QUIGGLE DD
MINEYAMA Y
Citation: Jd. Mccracken et al., ANTIPROLIFERATIVE EFFECTS OF THE ENANTIOMERS OF FLURBIPROFEN, Journal of clinical pharmacology, 36(6), 1996, pp. 540-545
Authors:
FORLAND SC
WECHTER WJ
WITCHWOOT S
CLIFFORD KH
ARNETT RL
CUTLER RE
Citation: Sc. Forland et al., HUMAN PLASMA-CONCENTRATIONS OF R-FLURBIPROFEN, S-FLURBIPROFEN, AND RACEMIC FLURBIPROFEN GIVEN AS A TOOTHPASTE, Journal of clinical pharmacology, 36(6), 1996, pp. 546-553
Citation: Wj. Wechter, UNDERSTANDING THE CHIRAL PHARMACOLOGY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN THE ARYL PROPIONIC-ACID CLASS - S(- OVERVIEW OF THE SYMPOSIUM UPDATE ON S(+)IBUPROFEN (GOING() IBUPROFEN )KITZBUEHL, AUSTRIA, FEBRUARY 2-4, 1996)/, Journal of clinical pharmacology, 36(12), 1996, pp. 1-2
Authors:
KANTOCI D
MURRAY ED
QUIGGLE DD
WECHTER WJ
Citation: D. Kantoci et al., ENDOGENOUS NATRIURETIC FACTORS .5. SYNTHESIS AND BIOLOGICAL-ACTIVITY OF A NATRIURETIC METABOLITE OF DILTIAZEM AND ITS DERIVATIVES, Journal of medicinal chemistry, 39(6), 1996, pp. 1196-1200
Authors:
MCCRACKEN JD
JACOBY RF
KANTOCI D
MURRAY ED
WECHTER WJ
Citation: Jd. Mccracken et al., THE EFFECT OF R-FLURBIPROFEN ON INHIBITION OF POLYP FORMATION IN THE MIN MOUSE MODEL, Gastroenterology, 110(4), 1996, pp. 555-555
Authors:
MURRAY ED
KANTOCI D
DEWIND SA
LEVINE BH
WECHTER WJ
Citation: Ed. Murray et al., ISOLATION AND CHARACTERIZATION OF HUMAN NATRIURETIC FACTORS LLU-ALPHA, LLU-BETA(1), AND LLU-GAMMA, The FASEB journal, 9(4), 1995, pp. 916-916
Authors:
MURRAY ED
KANTOCI D
DEWIND SA
BIGORNIA AE
DAMICO DC
KING JG
PHAM T
LEVINE BH
JUNG ME
WECHTER WJ
Citation: Ed. Murray et al., ENDOGENOUS NATRIURETIC FACTORS .3. ISOLATION AND CHARACTERIZATION OF HUMAN NATRIURETIC FACTORS LLU-ALPHA, LLU-BETA(1), AND LLU-GAMMA, Life sciences, 57(23), 1995, pp. 2145-2161
Authors:
WECHTER WJ
MCCRACKEN JC
ZENG QQ
BIGORNIA AE
LUI Y
KING J
Citation: Wj. Wechter et al., ON THE MECHANISM OF ENHANCEMENT OF THE GI TOXICITY OF S-FLURBIPROFEN BY ITS ENANTIOMER, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 221-221
Citation: Wj. Wechter et al., CHIRAL PHARMACOKINETICS OF RAC-FLURBIPROFEN AND PHARMACODYNAMICS OF ANABOLIC BONE RESPONSE IN THE NORMAL RAT, Chirality, 6(6), 1994, pp. 457-459
Citation: Wj. Wechter, DRUG CHIRALITY - ON THE MECHANISM OF R-ARYL PROPIONIC-ACID CLASS NSAIDS - EPIMERIZATION IN HUMANS AND THE CLINICAL IMPLICATIONS FOR THE USEOF RACEMATES, Journal of clinical pharmacology, 34(11), 1994, pp. 1036-1042